0000905148-20-001037.txt : 20200922
0000905148-20-001037.hdr.sgml : 20200922
20200922172121
ACCESSION NUMBER: 0000905148-20-001037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200918
FILED AS OF DATE: 20200922
DATE AS OF CHANGE: 20200922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic Fund, L.P.
CENTRAL INDEX KEY: 0001504130
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39512
FILM NUMBER: 201190282
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-522-0100
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic GP, L.P.
CENTRAL INDEX KEY: 0001770834
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39512
FILM NUMBER: 201190283
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-800-0800
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic GP, Ltd.
CENTRAL INDEX KEY: 0001770835
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39512
FILM NUMBER: 201190284
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-800-0800
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOODMAN COREY S
CENTRAL INDEX KEY: 0001278411
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39512
FILM NUMBER: 201190285
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Metacrine, Inc.
CENTRAL INDEX KEY: 0001634379
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472297384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3985 SORRENTO VALLEY BLVD., SUITE C
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-369-7800
MAIL ADDRESS:
STREET 1: 3985 SORRENTO VALLEY BLVD., SUITE C
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
form4.xml
X0306
4
2020-09-18
0001634379
Metacrine, Inc.
MTCR
0001504130
venBio Global Strategic Fund, L.P.
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
true
true
See Remarks
0001770834
venBio Global Strategic GP, L.P.
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
true
true
See Remarks
0001770835
venBio Global Strategic GP, Ltd.
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
true
true
See Remarks
0001278411
GOODMAN COREY S
1700 OWENS STREET
SUITE 595
SAN FRANCISCO
CA
94158
true
true
See Remarks
Common Stock
2020-09-18
4
P
0
230000
13
A
230000
D
Common Stock
2020-09-18
4
C
0
2829123
A
3059123
D
Series A Convertible Preferred Stock
2020-09-18
4
C
0
1960784
0
D
Common Stock
1960784
0
D
Series B Convertible Preferred Stock
2020-09-18
4
C
0
472250
0
D
Common Stock
472250
0
D
Series C Convertible Preferred Stock
2020-09-18
4
C
0
396089
0
D
Common Stock
396089
0
D
Every 5.1 shares of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
The shares are held by venBio Global Strategic Fund, L.P. venBio Global Strategic GP, L.P. is the general partner of venBio Global Strategic Fund, L.P. and venBio Global Strategic GP, Ltd. is the general partner of venBio Global Strategic GP, L.P. Corey Goodman is a director of venBio Global Strategic GP, Ltd. Each of venBio Global Strategic GP, L.P., venBio Global Strategic GP, Ltd. and Mr. Goodman disclaims beneficial ownership of such securities, except to the extent of its/his indirect pecuniary interest therein.
This Form 4 is being filed in conjunction with the Form 4 filed simultaneously by Robert Adelman, who serves on the Issuer's board of directors. Each of the reporting persons may be deemed directors of the Issuer by deputization of Dr. Adelman.
venBio Global Strategic Fund, L.P., by: venBio Global Strategic GP, L.P., its general partner, by: venBio Global Strategic GP, Ltd., its general partner, by: /s/ David Pezeshki, as attorney-in-fact
2020-09-22
venBio Global Strategic GP , L.P., by: venBio Global Strategic GP, Ltd., its general partner, by: /s/ David Pezeshki as attorney-in-fact
2020-09-22
venBio Global Strategic GP, Ltd., by: /s/ David Pezeshki, as attorney-in-fact
2020-09-22
Corey Goodman, by: /s/ David Pezeshki, as attorney-in-fact
2020-09-22